Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Spacek

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Breath Research|September 6, 2014
Changes in the concentration of breath ammonia in response to exercise: a preliminary investigationSteven F Solga, Matthew Mudalel, Lisa A Spacek, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 5, 2015
Breath ammonia and ethanol increase in response to a high protein challengeLisa A Spacek, Matthew L Mudalel, Rafal Lewicki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2005
Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, UgandaLisa A Spacek, Hasan M Shihab, Moses R Kamya, et al.
African Health Sciences|October 13, 2004
Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, UgandaMoses R Kamya, Fred C Semitala, Thomas C Quinn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and UgandaLisa A Spacek, Hasan M Shihab, Fred Lutwama, et al.
Journal of the International AIDS Society|March 6, 2009
Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteriaDavid Meya, Lisa A Spacek, Hilda Tibenderana, et al.
International Journal of STD & AIDS|February 9, 2006
Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, UgandaLisa A Spacek, Ronald H Gray, Maria J Wawer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapyFred Lutwama, Ronnie Serwadda, Harriet Mayanja-Kizza, et al.
Transfusion|November 17, 2010
Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in AfricaShixing Tang, Jiangqin Zhao, Ragupathy Viswanath, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapyMoses R Kamya, Harriet Mayanja-Kizza, Andrew Kambugu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Breath Research|September 6, 2014
Changes in the concentration of breath ammonia in response to exercise: a preliminary investigationSteven F Solga, Matthew Mudalel, Lisa A Spacek, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 5, 2015
Breath ammonia and ethanol increase in response to a high protein challengeLisa A Spacek, Matthew L Mudalel, Rafal Lewicki, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2005
Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, UgandaLisa A Spacek, Hasan M Shihab, Moses R Kamya, et al.
African Health Sciences|October 13, 2004
Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, UgandaMoses R Kamya, Fred C Semitala, Thomas C Quinn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and UgandaLisa A Spacek, Hasan M Shihab, Fred Lutwama, et al.
Journal of the International AIDS Society|March 6, 2009
Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteriaDavid Meya, Lisa A Spacek, Hilda Tibenderana, et al.
International Journal of STD & AIDS|February 9, 2006
Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, UgandaLisa A Spacek, Ronald H Gray, Maria J Wawer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapyFred Lutwama, Ronnie Serwadda, Harriet Mayanja-Kizza, et al.
Transfusion|November 17, 2010
Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in AfricaShixing Tang, Jiangqin Zhao, Ragupathy Viswanath, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapyMoses R Kamya, Harriet Mayanja-Kizza, Andrew Kambugu, et al.
Pageof 2